BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16926619)

  • 1. Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.
    Scahill L; McDougle CJ; Williams SK; Dimitropoulos A; Aman MG; McCracken JT; Tierney E; Arnold LE; Cronin P; Grados M; Ghuman J; Koenig K; Lam KS; McGough J; Posey DJ; Ritz L; Swiezy NB; Vitiello B;
    J Am Acad Child Adolesc Psychiatry; 2006 Sep; 45(9):1114-23. PubMed ID: 16926619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist.
    Scahill L; Dimitropoulos A; McDougle CJ; Aman MG; Feurer ID; McCracken JT; Tierney E; Pu J; White S; Lecavalier L; Hallett V; Bearss K; King B; Arnold LE; Vitiello B
    J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):97-107.e1. PubMed ID: 24342389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
    Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of the modified Children's Yale-Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials.
    Scahill L; Sukhodolsky DG; Anderberg E; Dimitropoulos A; Dziura J; Aman MG; McCracken J; Tierney E; Hallett V; Katz K; Vitiello B; McDougle C
    Autism; 2016 Feb; 20(2):145-52. PubMed ID: 25882391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
    Sukhodolsky DG; Scahill L; Gadow KD; Arnold LE; Aman MG; McDougle CJ; McCracken JT; Tierney E; Williams White S; Lecavalier L; Vitiello B
    J Abnorm Child Psychol; 2008 Jan; 36(1):117-28. PubMed ID: 17674186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity.
    Scahill L; Riddle MA; McSwiggin-Hardin M; Ort SI; King RA; Goodman WK; Cicchetti D; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):844-52. PubMed ID: 9183141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Home Situations Questionnaire-PDD version: factor structure and psychometric properties.
    Chowdhury M; Aman MG; Scahill L; Swiezy N; Arnold LE; Lecavalier L; Johnson C; Handen B; Stigler K; Bearss K; Sukhodolsky D; McDougle CJ
    J Intellect Disabil Res; 2010 Mar; 54(3):281-91. PubMed ID: 20377705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
    McDougle CJ; Scahill L; Aman MG; McCracken JT; Tierney E; Davies M; Arnold LE; Posey DJ; Martin A; Ghuman JK; Shah B; Chuang SZ; Swiezy NB; Gonzalez NM; Hollway J; Koenig K; McGough JJ; Ritz L; Vitiello B
    Am J Psychiatry; 2005 Jun; 162(6):1142-8. PubMed ID: 15930063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Children's Yale-Brown Obsessive Compulsive Scale in youth with autism spectrum disorders and obsessive-compulsive symptoms.
    Wu MS; McGuire JF; Arnold EB; Lewin AB; Murphy TK; Storch EA
    Child Psychiatry Hum Dev; 2014; 45(2):201-11. PubMed ID: 23827959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone.
    Masi G; Cosenza A; Mucci M; Brovedani P
    J Clin Psychiatry; 2003 Sep; 64(9):1039-47. PubMed ID: 14628979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
    King BH; Hollander E; Sikich L; McCracken JT; Scahill L; Bregman JD; Donnelly CL; Anagnostou E; Dukes K; Sullivan L; Hirtz D; Wagner A; Ritz L;
    Arch Gen Psychiatry; 2009 Jun; 66(6):583-90. PubMed ID: 19487623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting.
    Yucelen AG; Rodopman-Arman A; Topcuoglu V; Yazgan MY; Fisek G
    Compr Psychiatry; 2006; 47(1):48-53. PubMed ID: 16324902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.
    Goodman WK; Price LH; Rasmussen SA; Mazure C; Fleischmann RL; Hill CL; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1989 Nov; 46(11):1006-11. PubMed ID: 2684084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
    Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
    Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.
    Reddihough DS; Marraffa C; Mouti A; O'Sullivan M; Lee KJ; Orsini F; Hazell P; Granich J; Whitehouse AJO; Wray J; Dossetor D; Santosh P; Silove N; Kohn M
    JAMA; 2019 Oct; 322(16):1561-1569. PubMed ID: 31638682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale.
    Storch EA; Murphy TK; Geffken GR; Soto O; Sajid M; Allen P; Roberti JW; Killiany EM; Goodman WK
    Psychiatry Res; 2004 Nov; 129(1):91-8. PubMed ID: 15572188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining clinical severity in pediatric obsessive-compulsive disorder.
    Lewin AB; Piacentini J; De Nadai AS; Jones AM; Peris TS; Geffken GR; Geller DA; Nadeau JM; Murphy TK; Storch EA
    Psychol Assess; 2014 Jun; 26(2):679-84. PubMed ID: 24320764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.